Profile for Canada Patent: 2756690
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 2756690
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Mar 27, 2029 | Neurelis Inc | VALTOCO | diazepam |
| ⤷ Start Trial | Mar 27, 2029 | Neurelis Inc | VALTOCO | diazepam |
| ⤷ Start Trial | Mar 27, 2029 | Neurelis Inc | VALTOCO | diazepam |
| ⤷ Start Trial | Oct 16, 2032 | Neurelis Inc | VALTOCO | diazepam |
| ⤷ Start Trial | Jun 13, 2032 | Neurelis Inc | VALTOCO | diazepam |
| ⤷ Start Trial | Mar 27, 2029 | Neurelis Inc | VALTOCO | diazepam |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
